Efficacy of nivolumab in previously treated non-small cell lung cancer patients in japan: a multicenter retrospective cohort study.
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Nov 2018 Results assessing the characteristics and outcomes of previously treated patients with NSCLC treated with nivolumab who developed pseudoprogression (n=14) published in the Journal of Thoracic Oncology
- 10 Nov 2017 New trial record
- 18 Oct 2017 Results (n=394) presented at the 18th World Conference on Lung Cancer.